These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 24507237)

  • 1. [Evaluation of the consistency of three methods for testing HIV-1 genotype drug resistance].
    Li J; Jiang Y; Lü C; Wang J; Yao J
    Zhonghua Yu Fang Yi Xue Za Zhi; 2013 Nov; 47(11):1050-5. PubMed ID: 24507237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of an in-house genotyping resistance test for HIV-1 drug resistance interpretation and genotyping.
    Chen JH; Wong KH; Chan K; Lam HY; Lee SS; Li P; Lee MP; Tsang DN; Zheng BJ; Yuen KY; Yam WC
    J Clin Virol; 2007 Jun; 39(2):125-31. PubMed ID: 17449318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro study of resistance-associated genotypic mutations to nucleoside analogs.
    Gashnikova N; Plyasunova O; Kiseleva Y; Fedyuk N; Pokrovsky A
    Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):991-4. PubMed ID: 14565328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro analysis of synergism and antagonism of different nucleoside/nucleotide analogue combinations on the inhibition of human immunodeficiency virus type 1 replication.
    Perez-Olmeda M; Garcia-Perez J; Mateos E; Spijkers S; Ayerbe MC; Carcas A; Alcami J
    J Med Virol; 2009 Feb; 81(2):211-6. PubMed ID: 19107982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative analysis of ViroSeq and Trugene HIV-1 genotyping systems in the application to the virus variants in Russia].
    Kazennova EV; Vasil'ev AV; Korovina GI; Dvorkina SA; Vdovina VN; Ol'shanskiĭ AIa; Gevorkian MG; Rumiantseva OA; Bobkova MR
    Klin Lab Diagn; 2009 Dec; (12):46-51. PubMed ID: 20141003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of dried blood spot specimens for HIV-1 drug-resistance testing using the Trugene HIV-1 genotyping assay.
    Hallack R; Doherty LE; Wethers JA; Parker MM
    J Clin Virol; 2008 Apr; 41(4):283-7. PubMed ID: 18243787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimization of a low cost and broadly sensitive genotyping assay for HIV-1 drug resistance surveillance and monitoring in resource-limited settings.
    Zhou Z; Wagar N; DeVos JR; Rottinghaus E; Diallo K; Nguyen DB; Bassey O; Ugbena R; Wadonda-Kabondo N; McConnell MS; Zulu I; Chilima B; Nkengasong J; Yang C
    PLoS One; 2011; 6(11):e28184. PubMed ID: 22132237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative performance evaluation of the HIV-1 LiPA protease and reverse transcriptase resistance assay on clinical isolates.
    Tsongalis GJ; Gleeson T; Rodina M; Anamani D; Ross J; Joanisse I; Tanimoto L; Ziermann R
    J Clin Virol; 2005 Dec; 34(4):268-71. PubMed ID: 16286050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluations of an in-house drug resistance method for HIV-1 drug resistance using ViroSeq™ 2.0 genotyping system as a gold standard.
    Chaturbhuj DN; Deshmukh PS; Hingankar NK; Siddhaarth K; Deshpande SN; Sen S; Kabra S; Paranjape RS; Tripathy SP
    J Virol Methods; 2013 Apr; 189(1):87-92. PubMed ID: 23353551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human immunodeficiency virus type 1 drug resistance testing: Evaluation of a new ultra-deep sequencing-based protocol and comparison with the TRUGENE HIV-1 Genotyping Kit.
    Stelzl E; Pröll J; Bizon B; Niklas N; Danzer M; Hackl C; Stabentheiner S; Gabriel C; Kessler HH
    J Virol Methods; 2011 Dec; 178(1-2):94-7. PubMed ID: 21907239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High concordance between HIV-1 drug resistance genotypes generated from plasma and dried blood spots in antiretroviral-experienced patients.
    Masciotra S; Garrido C; Youngpairoj AS; McNulty A; Zahonero N; Corral A; Heneine W; de Mendoza C; García-Lerma JG
    AIDS; 2007 Nov; 21(18):2503-11. PubMed ID: 18025887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of drug-resistance genotypic assays among HIV-1 infected patients with predominantly CRF02_AG strains of HIV-1 in Abidjan, Cote d'Ivoire.
    Bilé EC; Adjé-Touré C; Borget MY; Kalou M; Diomande F; Chorba T; Nkengasong JN
    J Clin Virol; 2005 Jan; 32(1):60-6. PubMed ID: 15572008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a Novel In-house HIV-1 Genotype Drug Resistance Assay using Clinical Samples in China.
    Gao P; Yu F; Yang X; Li D; Shi Y; Wang Y; Zhang F
    Curr HIV Res; 2022; 20(1):32-41. PubMed ID: 34515004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of two commercially available sequence-based HIV-1 genotyping systems for the detection of drug resistance against HIV type 1 group M subtypes.
    Beddows S; Galpin S; Kazmi SH; Ashraf A; Johargy A; Frater AJ; White N; Braganza R; Clarke J; McClure M; Weber JN
    J Med Virol; 2003 Jul; 70(3):337-42. PubMed ID: 12766994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of three genotyping methods for the detection of HIV-1 resistance to antiretroviral drugs].
    Suárez A; Picazo J; Alonso R; Bouza E; Delgado R; Rodríguez-Noriega A; Bernal A; García A
    Rev Esp Quimioter; 2002 Mar; 15(1):43-48. PubMed ID: 12582436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations conferring resistance to zidovudine diminish the antiviral effect of stavudine plus didanosine.
    Izopet J; Bicart-See A; Pasquier C; Sandres K; Bonnet E; Marchou B; Puel J; Massip P
    J Med Virol; 1999 Dec; 59(4):507-11. PubMed ID: 10534734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of discrepancies in the interpretation of antiretroviral drug resistance results in HIV-1 infected patients of Basque Country, Spain.
    Muñoz M; Carmona R; Pérez-Alvarez L; Cilla G; Suarez MD; Delgado E; Contreras G; Corral J; de Goicoetxea MJ; Medrano L; Lezaún MJ; Nájera R;
    J Clin Virol; 2005 Jul; 33(3):224-9. PubMed ID: 15911444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [HIV-1 genotypic resistance profiles in children failing highly active antiretroviral therapy].
    Liu ZY; Wei HS; Zhao HX; Liu YN; Zhao Y; Han N; Cheng J; Zhang FJ
    Zhonghua Yi Xue Za Zhi; 2007 Dec; 87(46):3292-4. PubMed ID: 18396628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficacy of anti-HIV treatment and drug-resistance mutations in some parts of China].
    Han XX; Zhang M; Cui WG; Liu BG; Wang Yn; Zhang ZN; Liu J; Geng WQ; Diao YY; Dai D; Jiang YJ; Shang H
    Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(11):760-4. PubMed ID: 15949383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An international multicenter study on HIV-1 drug resistance testing by 454 ultra-deep pyrosequencing.
    Simen BB; Braverman MS; Abbate I; Aerssens J; Bidet Y; Bouchez O; Gabriel C; Izopet J; Kessler HH; Stelzl E; Di Giallonardo F; Schlapbach R; Radonic A; Paredes R; Recordon-Pinson P; Sakwa J; St John EP; Schmitz-Agheguian GG; Metzner KJ; Däumer MP;
    J Virol Methods; 2014 Aug; 204():31-7. PubMed ID: 24731928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.